Showing 201 - 220 results of 65,545 for search '(( e fold decrease ) OR ((( 50 mg decrease ) OR ( 5 ((a decrease) OR (nn decrease)) ))))', query time: 0.92s Refine Results
  1. 201
  2. 202
  3. 203

    R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

    Published 2022
    “…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
  4. 204

    R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

    Published 2022
    “…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Osteogenic differentiation of mesenchymal stem cells is enhanced in a 45S5-supplemented β-TCP composite scaffold: an <i>in-vitro</i> comparison of Vitoss and Vitoss BA - Fig 3 by Fabian Westhauser (5314436)

    Published 2019
    “…On D42 the fluorescence intensity of the BG particles decreased (h, *) compared to intensity at D21. Magnification: 40-fold.…”
  13. 213

    S5 Raw image - by Zhi Xuan Low (19270163)

    Published 2024
    “…Furthermore, the inclusion complex exhibited reduced systemic toxicity, including reduced inflammation in vital organs as examined by hematoxylin and eosin (H&E) staining. This study also revealed a notable sequential reduction in serum levels of tumour markers, including carcinoembryonic antigen (CEA) and mouse Cytochrome P450 1A2 (CYP1A2), correlating with a significant decrease in tumour bulk volume upon treatment commencement. …”
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220